Detalhe da pesquisa
1.
The Impact of Anlotinib on Brain Metastases of Non-Small Cell Lung Cancer: Post Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).
Oncologist;
25(5): e870-e874, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32077550
2.
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
Eur Respir J;
55(6)2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32269086
3.
A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung.
Mod Pathol;
33(4): 626-638, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31659278
4.
RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells.
Mol Carcinog;
56(11): 2391-2399, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28418088
5.
NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer.
Biochem Biophys Res Commun;
458(2): 381-6, 2015 Mar 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25646694
6.
Efficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinoma.
Chin J Cancer Res;
26(6): 705-10, 2014 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25561769
7.
Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era.
Clin Transl Oncol;
26(2): 434-445, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37436674
8.
Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma.
Neoplasia;
54: 101013, 2024 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38850835
9.
The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial.
Signal Transduct Target Ther;
9(1): 93, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38637495
10.
Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes.
J Thorac Oncol;
19(4): 601-612, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37981218
11.
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study.
J Cancer Res Clin Oncol;
149(2): 757-764, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35146575
12.
Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line Treatment for Advanced Nonsquamous NSCLC With Brain Metastases (CAP-BRAIN): A Multicenter, Open-Label, Single-Arm, Phase 2 Study.
J Thorac Oncol;
18(6): 769-779, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36738928
13.
Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis.
Eur J Med Res;
28(1): 267, 2023 Aug 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37542339
14.
Recurrent pleural effusion as a rare manifestation after prolonged PD1 inhibitor (camrelizumab)-based immunotherapy: A case report.
Hum Vaccin Immunother;
19(2): 2240689, 2023 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37529904
15.
A retrospective real-world experience of immunotherapy in patients with extensive stage small-cell lung cancer.
Cancer Med;
12(14): 14881-14891, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37462138
16.
A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study.
Clin Drug Investig;
43(5): 347-357, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37097608
17.
Combined small cell lung cancer: current progress and unmet needs.
Am J Cancer Res;
13(9): 3864-3874, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37818075
18.
Risk mapping of lung cancer: a comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies.
J Cancer Res Clin Oncol;
149(10): 6857-6873, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36809502
19.
The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research.
Front Oncol;
12: 864367, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35692799
20.
Dynamic monitoring serum tumor markers to predict molecular features of EGFR-mutated lung cancer during targeted therapy.
Cancer Med;
11(16): 3115-3125, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35543090